Strategies to express factor VIII gene constructs in the ovine mammary gland

Theriogenology - Tập 39 - Trang 137-149 - 1993
R. Halter1, J. Carnwath2, G. Espanion2, D. Herrmann2, E. Lemme2, H. Niemann2, D. Paul1
1Fraunhofer Institut für Toxikologie und Molekularbiologie, 3000 Hannover 61, Nicolai-Fuchs-Strasse 1, Germany
2Institut für Tierzucht und Tierverhalten (FAL), Mariensee, 3057 Neustadt 1, Germany

Tài liệu tham khảo

Ramabhadran, 1987, Products from genetically engineered mammalian cells: benefits and risk factors, Trends in Biotechnol., 5, 175, 10.1016/0167-7799(87)90092-8 Parekh, 1989, N-glycosylation and the production of recombinant glycoproteins, Trends in Biotechnol., 7, 117, 10.1016/0167-7799(89)90087-5 Westphal, 1989, Transgenic mammals and biotechnology, FASEB J., 3, 117, 10.1096/fasebj.3.2.2492478 Gordon, 1987, Production of human tissue plasminogen activator in transgenic mice, Bio/Technology, 5, 1183, 10.1038/nbt1187-1183 Pittius, 1988, A milk protein gene promoter directs the expression of human tissue plasminogen activator cDNA to the mammary gland in transgenic mice, 85, 5874 Wright, 1991, High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep, Bio/Technology, 9, 830, 10.1038/nbt0991-830 Vehar, 1984, Structure of human factor VIII, Nature, 312, 337, 10.1038/312337a0 Pittman, 1989, Structure-function relationships of factor VIII elucidated through recombinant DNA technology, Thromb. Haemostasis, 62, 161 Higuchi, 1991, Molecular characterization of severe hemophilia A suggests that about half the mutations are not within the coding regions and splice junctions of the factor VIII gene, 88, 7405 Figueiredo, 1992, A novel deletion of FVIII gene associated with variable levels of FVIII inhibitor, Eur. J. Haematol., 48, 152, 10.1111/j.1600-0609.1992.tb00587.x Wood, 1984, Expression of active human factor VIII from recombinant DNA clones, Nature, 312, 330, 10.1038/312330a0 Kaufman, 1989, Genetic engineering of factor VIII, Nature, 342, 207, 10.1038/342207a0 Kaufman, 1989, Genetic engineering of factor VIII, Nature, 342, 207, 10.1038/342207a0 Ali, 1988, Ovine beta-lactoglobulin gene structure, J. Mol. Biol., 199, 415, 10.1016/0022-2836(88)90614-6 Glanville, 1981, Structure of mouse metallothionein-I gene and its mRNA, Nature, 292, 267, 10.1038/292267a0 Wall, 1991, High-level synthesis of a heterologous milk protein in the mammary glands of transgenic swine, 88, 1696 Simons, 1987, Alteration of the quality of milk by expression of sheep β-lactoglobulin in transgenic mice, Nature, 328, 530, 10.1038/328530a0 Brinster, 1988, Introns increase transcriptional efficiency in transgenic mice, 85, 836 Choi, 1991, A generic intron increases gene expression in transgenic mice, Mol. Cell. Biol., 11, 3070, 10.1128/MCB.11.6.3070 Palmiter, 1991, Heterologous introns can enhance expression of transgenes in mice, 88, 478 Whitelaw, 1991, Targeting expression to the mammary gland: intronic sequences can enhance the efficiency of gene expression in transgenic mice, Transgenic Research, 1, 3, 10.1007/BF02512991 Toole, 1986, A large region (247 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity, 83, 5939 Hogan, 1986 Sambrock, 1989 Niemann, 1992, Generation of transgenic sheep harbouring the human blood clotting factor VIII gene, Theriogenology, 37, 265, 10.1016/0093-691X(92)90334-N